CLEC4D and COVID-19: The hub genes were mostly enriched in JAK-STAT, PI3K-Akt, C-type lectin receptor, TNF, and IL-17 signaling pathways, which suggested that the compounds in SHXP may treat COVID-19 through the above pathways by acting on related targets (Fig. 5).